3lbz
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
<StructureSection load='3lbz' size='340' side='right'caption='[[3lbz]], [[Resolution|resolution]] 2.30Å' scene=''> | <StructureSection load='3lbz' size='340' side='right'caption='[[3lbz]], [[Resolution|resolution]] 2.30Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[3lbz]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[3lbz]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3LBZ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3LBZ FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=Z88:N-[(4-BROMOPHENYL)SULFONYL]ACETAMIDE'>Z88</scene>, <scene name='pdbligand=Z89:(2R)-2-[(5Z)-5-(5-BROMO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-3-YL]BUTANEDIOIC+ACID'>Z89</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.3Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=Z88:N-[(4-BROMOPHENYL)SULFONYL]ACETAMIDE'>Z88</scene>, <scene name='pdbligand=Z89:(2R)-2-[(5Z)-5-(5-BROMO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-3-YL]BUTANEDIOIC+ACID'>Z89</scene></td></tr> | |
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3lbz FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3lbz OCA], [https://pdbe.org/3lbz PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3lbz RCSB], [https://www.ebi.ac.uk/pdbsum/3lbz PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3lbz ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3lbz FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3lbz OCA], [https://pdbe.org/3lbz PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3lbz RCSB], [https://www.ebi.ac.uk/pdbsum/3lbz PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3lbz ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Disease == | == Disease == | ||
- | + | [https://www.uniprot.org/uniprot/BCL6_HUMAN BCL6_HUMAN] Note=Chromosomal aberrations involving BCL6 may be a cause of B-cell non-Hodgkin lymphoma. Translocation t(3;14)(q27;q32); translocation t(3;22)(q27;q11) with immunoglobulin gene regions. Note=A chromosomal aberration involving BCL6 may be a cause of a form of B-cell leukemia. Translocation t(3;11)(q27;q23) with POU2AF1/OBF1. Note=A chromosomal aberration involving BCL6 may be a cause of lymphoma. Translocation t(3;4)(q27;p11) with ARHH/TTF. | |
== Function == | == Function == | ||
- | + | [https://www.uniprot.org/uniprot/BCL6_HUMAN BCL6_HUMAN] Transcriptional repressor which is required for germinal center formation and antibody affinity maturation. Probably plays an important role in lymphomagenesis.<ref>PMID:9649500</ref> <ref>PMID:18280243</ref> | |
== Evolutionary Conservation == | == Evolutionary Conservation == | ||
[[Image:Consurf_key_small.gif|200px|right]] | [[Image:Consurf_key_small.gif|200px|right]] | ||
Line 38: | Line 38: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: Ghetu | + | [[Category: Ghetu AF]] |
- | [[Category: Prive | + | [[Category: Prive GG]] |
- | + | ||
- | + |
Current revision
Crystal Structure of the BCL6 BTB domain complexed with the small molecule inhibitor 79-6
|